BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 30817859)

  • 21. Excellent outcomes of liver transplantation using severely steatotic grafts from brain-dead donors.
    Wong TC; Fung JY; Chok KS; Cheung TT; Chan AC; Sharr WW; Dai WC; Chan SC; Lo CM
    Liver Transpl; 2016 Feb; 22(2):226-36. PubMed ID: 26359934
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Safety of hepatitis B virus core antibody-positive grafts in liver transplantation: A single-center experience in China.
    Lei M; Yan LN; Yang JY; Wen TF; Li B; Wang WT; Wu H; Xu MQ; Chen ZY; Wei YG
    World J Gastroenterol; 2018 Dec; 24(48):5525-5536. PubMed ID: 30622380
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of severely steatotic grafts in liver transplantation: a matched case-control study.
    McCormack L; Petrowsky H; Jochum W; Mullhaupt B; Weber M; Clavien PA
    Ann Surg; 2007 Dec; 246(6):940-6; discussion 946-8. PubMed ID: 18043095
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Not All Cellular Rejections Are the Same: Differences in Early and Late Hepatic Allograft Rejection.
    Jadlowiec CC; Morgan PE; Nehra AK; Hathcock MA; Kremers WK; Heimbach JK; Wiesner RH; Taner T
    Liver Transpl; 2019 Mar; 25(3):425-435. PubMed ID: 30615251
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use, Safety, and Effectiveness of Viremic Hepatitis B Virus Donor Livers: A Potential Opportunity to Expand the Donor Pool.
    Lee TC; Kaiser TE; Luckett K; Wima K; Winer LK; Morris MC; Kassam AF; Safdar K; Bari K; Anwar N; Quillin RC; Shah SA
    Liver Transpl; 2019 Oct; 25(10):1581-1584. PubMed ID: 31273919
    [No Abstract]   [Full Text] [Related]  

  • 26. Short- and long-term outcomes after steatotic liver transplantation.
    Doyle MB; Vachharajani N; Wellen JR; Anderson CD; Lowell JA; Shenoy S; Brunt EM; Chapman WC
    Arch Surg; 2010 Jul; 145(7):653-60. PubMed ID: 20644128
    [TBL] [Abstract][Full Text] [Related]  

  • 27. What are the outcomes of declining a public health service increased risk liver donor for patients on the liver transplant waiting list?
    Croome KP; Lee DD; Pungpapong S; Keaveny AP; Taner CB
    Liver Transpl; 2018 Apr; 24(4):497-504. PubMed ID: 29341398
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Steatotic livers. Can we use them in OLTX? Outcome data from a prospective baseline liver biopsy study.
    Gabrielli M; Moisan F; Vidal M; Duarte I; Jiménez M; Izquierdo G; Domínguez P; Méndez J; Soza A; Benitez C; Pérez R; Arrese M; Guerra J; Jarufe N; Martínez J
    Ann Hepatol; 2012; 11(6):891-8. PubMed ID: 23109453
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Donor Hepatic Steatosis and Outcome After Liver Transplantation: a Systematic Review.
    Chu MJ; Dare AJ; Phillips AR; Bartlett AS
    J Gastrointest Surg; 2015 Sep; 19(9):1713-24. PubMed ID: 25917535
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical experience gained from the use of 120 steatotic donor livers for orthotopic liver transplantation.
    Verran D; Kusyk T; Painter D; Fisher J; Koorey D; Strasser S; Stewart G; McCaughan G
    Liver Transpl; 2003 May; 9(5):500-5. PubMed ID: 12740794
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Liver Transplantation with "Hors Tour" Allocated Versus Standard MELD Allocated Grafts: Single-Center Audit and Impact on the Liver Pool in France.
    Azoulay D; Disabato M; Gomez-Gavara C; Feray C; Salloum C; Ngonggang N; Winter A; Hentati H; Levesque E; Lim C; Compagnon P
    World J Surg; 2020 Mar; 44(3):912-924. PubMed ID: 31832704
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Surgical Aspects of Liver Transplantation and Domino Liver Transplantation in Maple Syrup Urine Disease: Analysis of 15 Donor-Recipient Pairs.
    Herden U; Grabhorn E; Santer R; Li J; Nadalin S; Rogiers X; Scherer MN; Braun F; Beime J; Lenhartz H; Muntau AC; Fischer L
    Liver Transpl; 2019 Jun; 25(6):889-900. PubMed ID: 30712285
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Feasibility and Safety of Split-Liver Transplantation in a Nascent Framework of Deceased Donation.
    Cherukuru R; Reddy MS; Shanmugam NP; Rajalingam R; Kota V; Gunasekaran V; Narasimhan G; Kaliamoorthy I; Rela M
    Liver Transpl; 2019 Mar; 25(3):450-458. PubMed ID: 30586233
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Attitudes and barriers to the use of donation after cardiac death livers: Comparison of a United States transplant center survey to the united network for organ sharing data.
    Sher L; Quintini C; Fayek SA; Abt P; Lo M; Yuk P; Ji L; Groshen S; Case J; Marsh CL
    Liver Transpl; 2017 Nov; 23(11):1372-1383. PubMed ID: 28834180
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Longterm renal allograft survival after sequential liver-kidney transplantation from a single living donor.
    Kitajima K; Ogawa Y; Miki K; Kai K; Sannomiya A; Iwadoh K; Murakami T; Koyama I; Nakajima I; Fuchinoue S
    Liver Transpl; 2017 Mar; 23(3):315-323. PubMed ID: 27862900
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safe use of highly steatotic livers by utilizing a donor/recipient clinical algorithm.
    Chavin KD; Taber DJ; Norcross M; Pilch NA; Crego H; McGillicuddy JW; Bratton CF; Lin A; Baliga PK
    Clin Transplant; 2013; 27(5):732-41. PubMed ID: 23991646
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Living Donor Liver Transplantation Using Selected Grafts With 2 Bile Ducts Compared With 1 Bile Duct Does Not Impact Patient Outcome.
    Kollmann D; Goldaracena N; Sapisochin G; Linares I; Selzner N; Hansen BE; Bhat M; Cattral MS; Greig PD; Lilly L; McGilvray ID; Ghanekar A; Grant DR; Selzner M
    Liver Transpl; 2018 Nov; 24(11):1512-1522. PubMed ID: 30264930
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of steatosis donor liver transplantation on hepatocellular carcinoma recurrence: experience at a single institution.
    Teng da H; Zhu ZJ; Zheng H; Deng YL; Sun LY; Pan C; Liu YH; Song HL; Shen ZY
    Hepatogastroenterology; 2012 May; 59(115):858-62. PubMed ID: 22389257
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Steatosis in Liver Transplantation: Current Limitations and Future Strategies.
    Linares I; Hamar M; Selzner N; Selzner M
    Transplantation; 2019 Jan; 103(1):78-90. PubMed ID: 30418431
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combined liver-dual kidney transplant: Role in expanded donors.
    Di Laudo M; Ravaioli M; La Manna G; Comai G; Cescon M; Del Gaudio M; Zanfi C; Cucchetti A; Ercolani G; Pinna AD
    Liver Transpl; 2017 Jan; 23(1):28-34. PubMed ID: 27113672
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.